PAK5 and cancer: In this study we discovered that in the context of esophageal cancers where abnormal expression of Aurora-A induced cell resistance to CDDP treatment, PAK7 upregulation and thereby inhibition of apoptosis, is of vital importance, suggesting that PAK7 may be a promising therapeutic target candidate in cancer treatment.